General
Preferred name
LOMITAPIDE
Synonyms
BMS-201038 ()
AEGR-733 ()
Lomitapide (mesylate) ()
LOMITAPIDE MESYLATE ()
AEGR-733 mesylate ()
BMS-201038 mesylate ()
AEGR-733, BMS-201038 ()
AEGR-733 Mesylate,BMS-2138 Mesylate ()
Lojuxta ()
BMS-201038-01 ()
Aegr-733 mesilate ()
AEGR-733 MESYLATE ()
Juxtapid ()
BMS-201038-04 ()
Lomitapide mesilate ()
Lomitapide-d8 ()
P&D ID
PD009190
CAS
182431-12-5
202914-84-9
2459377-96-7
Tags
available
drug
Approved by
FDA
First approval
2012
Drug Status
investigational
approved
Drug indication
Familial hypercholesterolemia
Max Phase
Phase 4
Probe control
Probe control not defined
Orthogonal probes
0
No orthogonal probes found
Similar probes
0
No structurally similar probes found
Structure formats
[[ format ]]
[[ compound[format === 'MOL' ? 'molblock' : format.toLowerCase()] ]]
Description
(extracted from source data)
DESCRIPTION
Lomitapide is a lipid-lowering agent for the treatment of familial hypercholesterolemia.
(GtoPdb)
DESCRIPTION
Lomitapide Mesylate is a potent microsomal triglyceride transfer protein (MTP) inhibitor, used in the treatment of familial hypercholesterolemia.
(BOC Sciences Bioactive Compounds)
[[ p.pathway_name ]]
[[ compound.targets[tid].gene_name ]]
Compound Sets
23
AdooQ Bioactive Compound Library
Axon Medchem Screening Library
BOC Sciences Bioactive Compounds
ChEMBL Approved Drugs
ChEMBL Drugs
Drug Repurposing Hub
DrugBank
DrugBank Approved Drugs
DrugCentral
DrugCentral Approved Drugs
DrugMAP
DrugMAP Approved Drugs
EU-OPENSCREEN Bioactive Compound Library
Guide to Pharmacology
LSP-MoA library (Laboratory of Systems Pharmacology)
Mcule NIBR MoA Box Subset
NCATS Inxight Approved Drugs
Novartis Chemogenetic Library (NIBR MoA Box)
ReFrame library
Selleckchem Bioactive Compound Library
TargetMol Bioactive Compound Library
[[ a.name ]]
[[ ligand_id ]]
free of charge
External IDs
46
Properties
(calculated by RDKit )
Molecular Weight
693.28
Hydrogen Bond Acceptors
3
Hydrogen Bond Donors
2
Rotatable Bonds
10
Ring Count
6
Aromatic Ring Count
4
cLogP
8.38
TPSA
61.44
Fraction CSP3
0.33
Chiral centers
0.0
Largest ring
6.0
QED
0.13
Structural alerts
0
No structural alerts detected
Custom attributes
(extracted from source data)
Pathway
Metabolism
Metabolic Enzyme/Protease
Target
MTP
MTTP
MTP inhibitor
Microsomal Triglyceride Transfer Protein (MTP)
Member status
member
MOA
Microsomal Triglyceride Transfer Protein (MTTP) Inhibitors
microsomal trigylceride transfer protein inhibitor
Indication
hypercholesterolemia
Source data